XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2017
Sep. 30, 2016
Current assets:    
Cash and cash equivalents $ 592,616 $ 516,112
Restricted cash 6,187 3,645
Short-term investments 247,665 121,629
Accounts receivable, net of allowance for doubtful accounts of $3,279 and $2,370 82,102 75,688
Inventories 19,950 16,354
Prepaid expenses and other current assets 29,790 26,302
Total current assets 978,310 759,730
Long-term investments 303,320 393,904
Property, plant, and equipment, net 476,353 443,656
Intangible assets, net 196,494 215,342
Goodwill 309,911 309,616
Deferred taxes 178,466 166,790
Other non-current assets 30,252 21,068
Total assets 2,473,106 2,310,106
Current liabilities:    
Accounts payable 12,728 17,544
Accrued liabilities 176,985 169,055
Income taxes payable 852 2,304
Deferred revenue 22,835 24,180
Total current liabilities 213,400 213,083
Long-term deferred revenue 36,123 35,366
Other non-current liabilities 101,204 82,922
Total liabilities 350,727 331,371
Stockholders' equity:    
Additional paid-in capital 51,426 42,032
Retained earnings 2,075,559 1,938,320
Accumulated other comprehensive (loss) (11,518) (10,197)
Total stockholders’ equity – Dolby Laboratories, Inc. 2,115,568 1,970,256
Controlling interest 6,811 8,479
Total stockholders’ equity 2,122,379 1,978,735
Total liabilities and stockholders’ equity 2,473,106 2,310,106
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 57,885,128 shares issued and outstanding at June 30, 2017 and 57,018,362 at September 30, 2016    
Stockholders' equity:    
Common stock 57 57
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 44,073,597 shares issued and outstanding at June 30, 2017 and 44,403,847 at September 30, 2016    
Stockholders' equity:    
Common stock $ 44 $ 44